Assessment of buccal aerosolized midazolam for pediatric conscious sedation.
To assess the acceptance and efficacy of aerosolized midazolam through buccal mucosa for conscious sedation. Thirty-five children aged 2-6 years with Grade I and II Frankl behavior rating scale were selected for various dental procedures under local anesthesia. Initially behavior-shaping procedures were used and Houpt behavior scoring was recorded. Thereafter, midazolam was administered using a spray through buccal mucosa and scores for acceptance of drug and behavior after sedation were recorded. The data were compiled and a Wilcoxon signed ranks test was used to assess the difference in behavior before and after the sedation. Eighty-three percent of the patients accepted the drug without any complaint. A statistically significant improvement was seen in the Houpt scores before and after drug administration (P < 0.001). Buccal aerosolized midazolam can be used successfully for pediatric conscious sedation.